Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-cd20 monoclonal antibody rituximab
Author:
Publisher
Wiley
Subject
Hematology,Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2257.2006.00738.x/fullpdf
Reference7 articles.
1. Chronic cold agglutinin disease of the “idiopathic” type is a premalignant or low-grade malignant lymphoproliferative disease
2. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease
3. Complete, long-term remission of refractory idiopathic cold haemagglutinin disease after mabthera
4. Fludarabine-induced hemolytic anemia: successful treatment by rituximab
5. Successful treatment of lymphoma with fludarabine combined with rituximab after immune thrombocytopenia induced by fludarabine
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rituximab in Chronic Lymphocytic Leukemia;Seminars in Hematology;2010-04
2. Rituximab-induced nonspecific interstitial pneumonia like reaction in a patient with idiopathic thrombocytopenic purpura;Respiratory Medicine CME;2009
3. Definition, classification and characterization of anemia in cancer;Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology;2008
4. Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy;Hematology;2007-10
5. Management of cold haemolytic syndrome;British Journal of Haematology;2007-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3